Maximilian Pfau

Company: Roche

Job title: Snr Principal Medical Director

Seminars:

Developing Novel Endpoints: Defining Measurable Outcomes That Capture Clinical Meaning and Accelerate Dry AMD Drug Development 1:00 pm

Measuring the rate of change in the macular area of photoreceptor loss, assessed by spectral domain-optical coherence tomography (SD-OCT) and ellipsoid zone (EZ) mapping. Regulatory challenges when using a novel endpoint Insights from a late-stage trial design utilizing a novel structural-functional endpoint Read more

day: Day1